Brief: Initiator Pharma Obtains Patent In Europe

Initiator Pharma A/S

09/08/2023 08:13

Aug 9 (Reuters) - Initiator Pharma A/S  INIT.ST :
    * INITIATOR PHARMA OBTAINS IP2018 PATENT IN EUROPE FOR
TREATMENT
OF ERECTILE DYSFUNCTION AND DEPRESSION
    * PATENT GRANTED BY EPO AS EP 4009942 B1 CONCERNS COMPANY'S
PRODUCT CANDIDATE IP2018 FOR TREATMENT OF ERECTILE DYSFUNCTION
(ED) AND DEPRESSION.
    * GRANTED PATENT CONFERS PROTECTION IN EUROPE UNTIL 2040
    * CORRESPONDING PATENTS HAVE PREVIOUSLY BEEN GRANTED IN
ISRAEL AND
SOUTH AFRICA, AND APPLICATIONS ARE PENDING IN A LARGE NUMBER OF
ADDITIONAL TERRITORIES SUCH AS, US, JAPAN AND CHINA.

Source text for Eikon:  ID:nMFN3ZxDK6 
Further company coverage:  INIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))